Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial

BACKGROUND: In an era of low local relapse rates after adjuvant breast radiotherapy, risks of late normal-tissue effects (NTE) need to be balanced against risk of relapse. NTE are assessed using patient-reported outcome measures (PROMs), clinician-reported outcomes (CRO) and photographs. This analys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiother Oncol
Main Authors: Bhattacharya, Indrani S., Haviland, Joanne S., Hopwood, Penelope, Coles, Charlotte E., Yarnold, John R., Bliss, Judith M., Kirby, Anna M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Scientific Publishers 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486395/
https://ncbi.nlm.nih.gov/pubmed/31005219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2019.01.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados